Taurolidine Lock in Long Term Parenteral Nutrition
Launched by STANLEY DUDRICK'S MEMORIAL HOSPITAL · Dec 10, 2013
Trial Information
Current as of September 03, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • home parenteral nutrition for at least months before enrollment
- • presence of central venous cathter
- Exclusion Criteria:
- • home nutrition \< 12 months
- • catheter in peripheral vein
About Stanley Dudrick's Memorial Hospital
Stanley Dudrick's Memorial Hospital is a leading healthcare institution committed to advancing medical research and improving patient care through innovative clinical trials. Named in honor of Dr. Stanley Dudrick, a pioneer in clinical nutrition, the hospital integrates state-of-the-art facilities and a dedicated team of healthcare professionals to facilitate rigorous and ethical research. The institution emphasizes collaboration with academic and industry partners to explore groundbreaking treatments and therapies, ensuring that the highest standards of safety and efficacy are upheld in all clinical studies. With a focus on diverse therapeutic areas, Stanley Dudrick's Memorial Hospital plays a vital role in translating scientific discoveries into tangible health benefits for the community and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Skawina, , Poland
Patients applied
Trial Officials
Stanislaw Klek, Assoc Prof
Principal Investigator
Stanley Dudrick's Memorial Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials